Value of black blood T2* cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Smith, Gillian C ^a,b   Carpenter, John Paul ^a,b   He, Taigang ^a,b   Alam, Mohammed H ^a,b   Firmin, David N ^a,b   Pennell, Dudley J ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADOLESCENT; ADULT; ARTICLE; ARTIFACT REDUCTION; BLACK BLOOD T2 CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; SCHOOL CHILD; THALASSEMIA MAJOR; ARTIFACT; BETA THALASSEMIA; BLOOD; BLOOD TRANSFUSION; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; HEART DISEASE; HEART MUSCLE; HEMOSIDEROSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PREDICTIVE VALUE;

ADOLESCENT; ADULT; ARTIFACTS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; FEMALE; HEART DISEASES; HEMOSIDEROSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 79958864832     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-21     Document Type: Article

References (18)

1. Survival and desferrioxamine in thalassaemia major. Modell B, Letsky EA, Flynn DM, Peto R, Weatherall DJ, Br Med J 1982 284 1081 4 10.1136/bmj.284.6322. 1081 (Pubitemid 12135972)
2. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A, Haematologica 2004 89 1187 93 15477202 (Pubitemid 39390442)
3. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJL, Circulation 2009 120 1961 8 10.1161/CIRCULATIONAHA.109.874487 19801505
4. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. Wolfe L, Olivieri N, Sallan D, Colan S, Rose V, Propper R, Freedman MH, Nathan DG, N Engl J Med 1985 312 1600 3 10.1056/ NEJM198506203122503 4000198 (Pubitemid 15062652)
5. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW, N Engl J Med 1994 331 567 73 10.1056/NEJM199409013310902 8047080 (Pubitemid 24265698)
6. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ, J Cardiovasc Magn Reson 2008 10 42 10.1186/1532-429X-10-42 18817553
7. Update on survival in thalassemia major. Telfer P, Hemoglobin 2009 33 76 80 10.3109/03630260903347336 20001636
8. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ, Eur Heart J 2001 22 2171 9 10.1053/euhj.2001.2822 11913479 (Pubitemid 33139463)
9. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ, J Magn Reson Imaging 2003 18 33 9 10.1002/jmri.10332 12815637 (Pubitemid 36791266)
10. International reproducibility of single breath-hold T2* magnetic resonance for cardiac and liver iron assessment among five thalassemia centers. Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WM, Au WY, Chu WC, Chan G, Galanello R, Matta G, Fogel M, Cohen AR, Tan RS, Chen K, Ng I, Lai A, Fucharoen S, Laothamatas J, Chuncharunee S, Firmin DN, Smith GS, Pennell DJ, J Magn Reson Imaging 2010 32 315 9 10.1002/jmri.22245 20677256
11. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R, Blood 2006 107 3738 44 10.1182/blood-2005-07-2948 16352815
12. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ, Circulation 2007 115 1876 84 10.1161/CIRCULATIONAHA.106. 648790 17372174 (Pubitemid 46598901)
13. Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. Pennell DJ, Porter JB, Cappellini MD, El-Beshlawy A, Chan LL, Aydinok Y, Elalfy MS, Sutcharitchan P, Li CK, Ibrahim H, Viprakasit V, Kattamis A, Smith G, Habr D, Domokos G, Roubert B, Taher A, Blood 2010 115 2364 71 10.1182/blood-2009-04-217455 19996412
14. Black-blood T2* technique for myocardial iron measurement in thalassemia. He T, Gatehouse PD, Kirk P, Tanner MA, Smith GC, Keegan J, Mohiaddin RH, Pennell DJ, Firmin DN, J Magn Reson Imaging 2007 25 1205 9 10.1002/jmri.20929 17520740 (Pubitemid 46870279)
15. In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T. Reeder SB, Faranesh AZ, Boxerman JL, McVeigh ER, Magn Reson Med 1998 39 988 98 10.1002/mrm.1910390617 9621923 (Pubitemid 28237758)
16. Improved R2* measurements in myocardial iron overload. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC, J Magn Reson Imaging 2006 23 9 16 10.1002/jmri.20467 16329085 (Pubitemid 43100712)
17. Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN, Magn Reson Med 2008 60 1082 9 10.1002/mrm.21744 18956471
18. Breath-Hold FLASH and FISP cardiovascular MR imaging: Left ventricular volume differences and reproducibility. Moon JC, Lorenz CH, Francis JM, Smith GC, Pennell DJ, Radiology 2002 223 789 97 10.1148/radiol.2233011181 12034951 (Pubitemid 34547599)